Globus Medical (GMED) said Thursday it has completed its all-cash $250 million acquisition of medical device company Nevro (NVRO).
The acquisition expands Globus Medical's footprint in the musculoskeletal market and unlocks a $2.5 billion market opportunity, the company said.
Nevro common stock ceased trading on the New York Stock Exchange before the market open on Thursday, Globus said.
Price: 72.15, Change: -3.35, Percent Change: -4.44
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.